XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities:    
Net loss $ (44,566) $ (11,325)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 8,481 5,269
Unrealized loss (gain) on foreign currency 142 (180)
Stock based compensation 3,940 138
Change in fair value of warrants 3,416  
Change in fair value of derivative liability 1,575  
Amortization of debt discount and deferred issuance costs 1,154  
Deferred income tax 507 (4,318)
Unrealized gain on investment (1,260)  
Noncash Lease Expense 4,690  
Changes in operating assets and liabilities:    
Accounts receivable 44,227 37,076
Prepaid expenses and other current assets and prepaid expenses and other assets 2,864 (9,073)
Accounts payable (5,741) (2,004)
Deferred rent   (2,498)
Accrued compensation (10,117) (1,083)
Accrued expenses, other current liabilities and other liabilities (4,688) (1,685)
Lease liabilities, net of right-of-use assets (5,517)  
Deferred revenue 1,461 (284)
Unrealized Gain (Loss) on Investments 1,260  
Provision for doubtful accounts 574 (515)
Cash provided by operating activities 1,142 9,518
Investing activities:    
Capital expenditures (2,369) (907)
Capitalization of internal-use software (3,553) (1,335)
Cash from acquired business, net   5,200
Cash (used in) provided by investing activities (5,922) 2,958
Financing activities:    
Proceeds from issuance of common stock   35,000
Proceeds from exercise of stock options 358 142
Deferred reverse recapitalization costs (585)  
Cash (used in) provided by financing activities (227) 35,142
Effect of currency translation on cash and cash equivalents (186) (534)
Net (decrease) increase in cash, cash equivalents and restricted cash (5,193) 47,084
Cash and cash equivalents and restricted cash at beginning of period 79,733 106,126
Cash and cash equivalents and restricted cash at end of period $ 74,540 $ 153,210